perospirone

Known as: 2-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)hexahydro-1H-isoindole-1,3-(2H)-dione 
 

Topic mentions per year

Topic mentions per year

1996-2018
051019962018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND Perospirone was developed in Japan and is used for the treatment of schizophrenia and related illnesses. The authors… (More)
Is this relevant?
2009
2009
We examined the efficacy and tolerability of perospirone, a dopamine D2 and 5-HT2A receptor antagonist and a partial 5-HT1A… (More)
Is this relevant?
2008
2008
An accumulating body of evidences point to the significance of neuroinflammation and immunogenetics in schizophrenia… (More)
Is this relevant?
2008
2008
Accumulating evidence suggests that the serotonin 5-HT(1A) receptor may play a role in the pathophysiology of schizophrenia. The… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Perospirone is a recently developed atypical antipsychotic with potent serotonin 5-HT2 and dopamine D2 antagonist activity. Other… (More)
Is this relevant?
2006
2006
Perospirone is an atypical antipsychotic agent originated and clinically used in Japan. Based on an in vitro study, it is… (More)
Is this relevant?
2004
2004
Perospirone is a novel atypical antipsychotic with a unique combination of 5-HT1A receptor agonism as well as 5-HT2A and D2… (More)
Is this relevant?
2003
2003
In vitro metabolism of perospirone was examined with rat, monkey and human liver S9, human liver microsomes and yeast microsomes… (More)
  • figure 2
  • figure 1
  • table I
  • table II
  • table III
Is this relevant?
2003
2003
Serum prolactin levels were investigated in 41 patients with schizophrenia who were receiving clinically effective doses of… (More)
  • figure 1
  • table 1
Is this relevant?
2003
2003
To investigate the effect of cis-N-[4-[4-(1,2-benz-isozole-3-yl)-1-piperazinyl]butyl] cyclohexane-1,2-dicarboximide hydrochloride… (More)
Is this relevant?